Archives

by in
Entry Author Date Location
Seattle Genetics’ Market Debut, Pathway Gets Bought, Theraclone’s Latest Trick Against HIV, & More Seattle-Area Life Sciences News 08/25/11 Seattle
Scientists Spot New Antibodies Against HIV, Opening Up Potential Path to AIDS Vaccine 08/17/11 National
iAMscientist, Backed by George Whitesides, Tries to Help Firms and Institutes Find Top Talent 02/23/11 Boston
Theraclone Raises $1.5M 03/19/10 Seattle
Targeted Genetics Lives On, CellCyte Charged With Fraud, Theraclone Finds HIV Weakness, & More Seattle-Area Life Sciences News 09/10/09 Seattle
Finding HIV’s Weak Spot, Scientists at Seattle’s Theraclone and San Diego’s Scripps See Opening for New Vaccine 09/03/09 National
Inovio, Fueled By Swine Flu Fear, Comes Back From Brink With ‘Universal’ Vaccines 08/25/09 San Diego
Targeted Genetics Dumps Lease, Amgen’s Dmab Works in Cancer Trial, Theraclone Nabs Cash, & More Seattle-Area Life Sciences News 07/09/09 Seattle
Theraclone Gets Funding for HIV 07/06/09 Seattle
Theraclone Sciences Garners New Financing 07/06/09 Seattle
Antibodies for HIV, Long Dismissed, Show Signs of Comeback at Seattle’s Theraclone 04/07/09 Seattle
PATH, Fueled by Bill Gates’ Fortune, Builds Global Health Hothouse in Seattle 02/04/09 Seattle
Scripps, IAVI to Establish $30 Million AIDS Vaccine Research Center 10/01/08 San Diego
Page 1 of 1